Works in Diabetes, Obesity & Metabolism, 2023, Vol 25, Issue 5

Results: 31

Cover Image.

Published in:

Diabetes, Obesity & Metabolism, 2023, v. 25, n. 5, p. 1, doi. 10.1111/dom.15067

By:

Andersen, Grit;
Eloy, Rosy;
Famulla, Susanne;
Heise, Tim;
Meiffren, Grégory;
Seroussi, Cyril;
Gaudier, Martin;
Mégret, Claire;
Chan, You‐Ping;
Soula, Olivier;
Riddle, Matthew

Publication type:

Article

Detecting and treating the protean manifestations of diabetic autonomic neuropathy.

Published in:

Diabetes, Obesity & Metabolism, 2023, v. 25, n. 5, p. 1162, doi. 10.1111/dom.15004

By:

Bell, David S. H.

Publication type:

Article

Safety and tolerability of semaglutide across the SUSTAIN and PIONEER phase IIIa clinical trial programmes.

Published in:

Diabetes, Obesity & Metabolism, 2023, v. 25, n. 5, p. 1385, doi. 10.1111/dom.14990

By:

Aroda, Vanita R.;
Erhan, Umut;
Jelnes, Peter;
Meier, Juris J.;
Abildlund, Morten Tind;
Pratley, Richard;
Vilsbøll, Tina;
Husain, Mansoor

Publication type:

Article

Cardiovascular outcomes trial data from EMPA‐REG OUTCOME, CAROLINA and CARMELINA: Assessment of a novel staging system for type 2 diabetes.

Published in:

Diabetes, Obesity & Metabolism, 2023, v. 25, n. 5, p. 1372, doi. 10.1111/dom.14989

By:

Dar, Moahad S.;
Wanner, Christoph;
Marx, Nikolaus;
Ofstad, Anne Pernille;
Mattheus, Michaela;
Kaspers, Stefan;
Bég, Sami A.

Publication type:

Article

Meta‐analysis of head‐to‐head clinical trials comparing incretin‐based glucose‐lowering medications and basal insulin: An update including recently developed glucagon‐like peptide‐1 (GLP‐1) receptor agonists and the glucose‐dependent insulinotropic polypeptide/GLP‐1 receptor co‐agonist tirzepatide

Published in:

Diabetes, Obesity & Metabolism, 2023, v. 25, n. 5, p. 1361, doi. 10.1111/dom.14988

By:

Nauck, Michael A.;
Mirna, Abd El Aziz;
Quast, Daniel R.

Publication type:

Article

Integrated safety and efficacy analysis of dasiglucagon for the treatment of severe hypoglycaemia in individuals with type 1 diabetes.

Published in:

Diabetes, Obesity & Metabolism, 2023, v. 25, n. 5, p. 1351, doi. 10.1111/dom.14987

By:

Heller, Simon;
Battelino, Tadej;
Bailey, Timothy S.;
Pieber, Thomas R.;
Hövelmann, Ulrike;
Plum‐Mörschel, Leona;
Melgaard, Anita E.;
Aronson, Ronnie;
DiMeglio, Linda A.;
Johansen, Thue;
Danne, Thomas

Publication type:

Article

Impact of baseline kidney function on the effects of sodium‐glucose co‐transporter‐2 inhibitors on kidney and heart failure outcomes: A systematic review and meta‐analysis of randomized controlled trials.

Published in:

Diabetes, Obesity & Metabolism, 2023, v. 25, n. 5, p. 1341, doi. 10.1111/dom.14986

By:

Maddaloni, Ernesto;
Cavallari, Ilaria;
La Porta, Ylenia;
Appetecchia, Alessandro;
D'Onofrio, Luca;
Grigioni, Francesco;
Buzzetti, Raffaella;
Holman, Rury R.

Publication type:

Article

Therapeutic inertia related to the injectable glucagon‐like peptide‐1 receptor agonists dulaglutide and semaglutide in patients with type 2 diabetes in UK primary care.

Published in:

Diabetes, Obesity & Metabolism, 2023, v. 25, n. 5, p. 1331, doi. 10.1111/dom.14985

By:

von Arx, Lill‐Brith;
Rachman, Jonathan;
Webb, Joanne;
Casey, Caroline;
Patel, Amisha;
Diomatari, Christina;
Wood, Robert;
Idris, Iskandar

Publication type:

Article

Effects of co‐ingesting glucose and whey protein on blood glucose, plasma insulin and glucagon concentrations, and gastric emptying, in older men with and without type 2 diabetes.

Published in:

Diabetes, Obesity & Metabolism, 2023, v. 25, n. 5, p. 1321, doi. 10.1111/dom.14983

By:

Oberoi, Avneet;
Giezenaar, Caroline;
Rigda, Rachael S.;
Horowitz, Michael;
Jones, Karen L.;
Chapman, Ian;
Soenen, Stijn

Publication type:

Article

Identifying diabetogenic drugs using real world health care databases: A Danish and Australian symmetry analysis.

Published in:

Diabetes, Obesity & Metabolism, 2023, v. 25, n. 5, p. 1311, doi. 10.1111/dom.14982

By:

Lund, Lars Christian;
Jensen, Patricia Hjorslev;
Pottegård, Anton;
Andersen, Morten;
Pratt, Nicole;
Hallas, Jesper

Publication type:

Article

Professional continuous glucose monitoring in patients with diabetes mellitus: A systematic review and meta‐analysis.

Published in:

Diabetes, Obesity & Metabolism, 2023, v. 25, n. 5, p. 1301, doi. 10.1111/dom.14981

By:

Di Molfetta, Sergio;
Caruso, Irene;
Cignarelli, Angelo;
Natalicchio, Annalisa;
Perrini, Sebastio;
Laviola, Luigi;
Giorgino, Francesco

Publication type:

Article

The role of dietary salt in metabolism and energy balance: Insights beyond cardiovascular disease.

Published in:

Diabetes, Obesity & Metabolism, 2023, v. 25, n. 5, p. 1147, doi. 10.1111/dom.14980

By:

Wu, Qi;
Burley, George;
Li, Li‐Cheng;
Lin, Shu;
Shi, Yan‐Chuan

Publication type:

Article

Long‐term cost‐effectiveness analysis of tirzepatide versus semaglutide 1.0 mg for the management of type 2 diabetes in the United States.

Published in:

Diabetes, Obesity & Metabolism, 2023, v. 25, n. 5, p. 1292, doi. 10.1111/dom.14979

By:

Valentine, William J.;
Hoog, Meredith;
Mody, Reema;
Belger, Mark;
Pollock, Richard

Publication type:

Article

Effects of canagliflozin on liver steatosis and fibrosis markers in patients with type 2 diabetes and chronic kidney disease: A post hoc analysis of the CREDENCE trial.

Published in:

Diabetes, Obesity & Metabolism, 2023, v. 25, n. 5, p. 1413, doi. 10.1111/dom.14978

By:

Koshino, Akihiko;
Oshima, Megumi;
Arnott, Clare;
Fletcher, Robert A.;
Bakris, George L.;
Jardine, Meg;
Mahaffey, Kenneth W.;
Perkovic, Vlado;
Pollock, Carol;
Heerspink, Hiddo J. L.;
Neuen, Brendon L.

Publication type:

Article

Pyridoxamine reduces methylglyoxal and markers of glycation and endothelial dysfunction, but does not improve insulin sensitivity or vascular function in abdominally obese individuals: A randomized double‐blind placebo‐controlled trial.

Published in:

Diabetes, Obesity & Metabolism, 2023, v. 25, n. 5, p. 1280, doi. 10.1111/dom.14977

By:

Van den Eynde, Mathias D. G.;
Houben, Alfons J. H. M.;
Scheijen, Jean L. J. M.;
Linkens, Armand M. A.;
Niessen, Petra M.;
Simons, Nynke;
Hanssen, Nordin M. J.;
Kusters, Yvo H. A. M.;
Eussen, Simone J. M. P.;
Miyata, Toshio;
Stehouwer, Coen D. A.;
Schalkwijk, Casper G.

Publication type:

Article

Effects of sodium‐glucose cotransporter 2 inhibitors, mineralocorticoid receptor antagonists, and their combination on albuminuria in diabetic patients.

Published in:

Diabetes, Obesity & Metabolism, 2023, v. 25, n. 5, p. 1271, doi. 10.1111/dom.14976

By:

Morita, Ryutaro;
Tsukamoto, Shunichiro;
Obata, Shota;
Yamada, Takayuki;
Uneda, Kazushi;
Uehara, Tatsuki;
Rehman, Muhammad Ebad;
Azushima, Kengo;
Wakui, Hiromichi;
Tamura, Kouichi

Publication type:

Article

Joint longitudinal and time‐to‐event modelling compared with standard Cox modelling in patients with type 2 diabetes with and without established cardiovascular disease: An analysis of the EXSCEL trial.

Published in:

Diabetes, Obesity & Metabolism, 2023, v. 25, n. 5, p. 1261, doi. 10.1111/dom.14975

By:

Oulhaj, Abderrahim;
Aziz, Faisal;
Suliman, Abubaker;
Iqbal, Nayyar;
Coleman, Ruth L.;
Holman, Rury R.;
Sourij, Harald

Publication type:

Article

iGlarLixi versus premixed insulin initiation in adults with type 2 diabetes advancing from basal insulin therapy: The SoliComplex real‐world study.

Published in:

Diabetes, Obesity & Metabolism, 2023, v. 25, n. 5, p. 1249, doi. 10.1111/dom.14974

By:

Lajara, Rosemarie;
Heller, Caroline;
Pantalone, Kevin M.;
Lew, Elisheva;
Li, Xuan;
Dex, Terry;
Kilpatrick, Catherine Rachel

Publication type:

Article

Patient perspectives and experiences with basal insulin titration in type 2 diabetes in the United States: A cross‐sectional survey.

Published in:

Diabetes, Obesity & Metabolism, 2023, v. 25, n. 5, p. 1408, doi. 10.1111/dom.14973

By:

Harris, Stewart B.;
Mohammedi, Kamel;
Bertolini, Monica;
White, John;
Walker, Valery;
Zhou, Fang Liz;
Anderson, John E.;
Seufert, Jochen

Publication type:

Article

A microbiome‐targeting fibre‐enriched nutritional formula is well tolerated and improves quality of life and haemoglobin A1c in type 2 diabetes: A double‐blind, randomized, placebo‐controlled trial.

Published in:

Diabetes, Obesity & Metabolism, 2023, v. 25, n. 5, p. 1203, doi. 10.1111/dom.14967

By:

Frias, Juan P.;
Lee, Martin L.;
Carter, Matthew M.;
Ebel, Emily R.;
Lai, Ren‐Hau;
Rikse, Lars;
Washington, Marc E.;
Sonnenburg, Justin L.;
Damman, Christopher J.

Publication type:

Article

A co‐formulation of pramlintide and insulin A21G (ADO09) improves postprandial glucose and short‐term control of mean glucose, time in range, and body weight versus insulin aspart in adults with type 1 diabetes.

Published in:

Diabetes, Obesity & Metabolism, 2023, v. 25, n. 5, p. 1241, doi. 10.1111/dom.14972

By:

Andersen, Grit;
Eloy, Rosy;
Famulla, Susanne;
Heise, Tim;
Meiffren, Grégory;
Seroussi, Cyril;
Gaudier, Martin;
Mégret, Claire;
Chan, You‐Ping;
Soula, Olivier;
Riddle, Matthew

Publication type:

Article

Efficacy and safety of basal‐first titration order in individuals with type 2 diabetes receiving short‐term intensive insulin therapy: An exploratory analysis of BEYOND V.

Published in:

Diabetes, Obesity & Metabolism, 2023, v. 25, n. 5, p. 1221, doi. 10.1111/dom.14970

By:

Li, Yijun;
Yu, Dongni;
Guo, Lixin;
Mu, Yiming;
Wan, Hailong;
Wang, Junfen;
Xu, Binhua;
Wang, Guoping;
Jiang, Chengxia;
Liang, Li;
Zhang, Jiewen;
Liu, Jingcheng;
Zhang, Minlu;
Cui, Nan

Publication type:

Article

Beta‐cell function in treatment‐naïve patients with type 2 diabetes mellitus: Analyses of baseline data from 15 clinical trials.

Published in:

Diabetes, Obesity & Metabolism, 2023, v. 25, n. 5, p. 1403, doi. 10.1111/dom.14969

By:

Blüher, Matthias;
Malhotra, Ankur;
Bader, Giovanni

Publication type:

Article

Liver‐expressed antimicrobial peptide 2 is associated with improved pancreatic insulin secretion in adults with overweight and obesity.

Published in:

Diabetes, Obesity & Metabolism, 2023, v. 25, n. 5, p. 1213, doi. 10.1111/dom.14968

By:

Stark, Romana;
Feehan, Jack;
Mousa, Aya;
Andrews, Zane B.;
de Courten, Barbora

Publication type:

Article

Lifestyle intervention for the prevention of type 2 diabetes in women with prior gestational diabetes: A systematic review and meta‐analysis.

Published in:

Diabetes, Obesity & Metabolism, 2023, v. 25, n. 5, p. 1196, doi. 10.1111/dom.14966

By:

Retnakaran, Matthew;
Viana, Luciana V.;
Kramer, Caroline K.

Publication type:

Article

Efficacy and safety of janagliflozin monotherapy in Chinese patients with type 2 diabetes mellitus inadequately controlled on diet and exercise: A multicentre, randomized, double‐blind, placebo‐controlled, Phase 3 trial.

Published in:

Diabetes, Obesity & Metabolism, 2023, v. 25, n. 5, p. 1229, doi. 10.1111/dom.14971

By:

Ji, Linong;
Jiang, Xiaozhen;
Hao, Qingshun;
Cheng, Zhifeng;
Wang, Kun;
Pang, Shuguang;
Liu, Meiying;
Guo, Yushan;
Chen, Xiaowen;
Su, Xiuhai;
Ning, Tao;
Liu, Jie;
Bian, Fang;
Li, Yulan;
Zhang, Zhinong;
Song, Weihong;
Sun, Jingfang

Publication type:

Article

Potential for residual cardiovascular risk reduction: Eligibility for icosapent ethyl in the VERTIS CV population with type 2 diabetes and atherosclerotic cardiovascular disease.

Published in:

Diabetes, Obesity & Metabolism, 2023, v. 25, n. 5, p. 1398, doi. 10.1111/dom.14965

By:

Kim, Joseph M.;
Bhatt, Deepak L.;
Dagogo‐Jack, Samuel;
Cherney, David Z. I.;
Cosentino, Francesco;
McGuire, Darren K.;
Pratley, Richard E.;
Liu, Chih‐Chin;
Cater, Nilo B.;
Frederich, Robert;
Mancuso, James P.;
Cannon, Christopher P.

Publication type:

Article

Exercise‐related hypoglycaemia induces QTc‐interval prolongation in individuals with type 1 diabetes.

Published in:

Diabetes, Obesity & Metabolism, 2023, v. 25, n. 5, p. 1186, doi. 10.1111/dom.14964

By:

Hagelqvist, Per G.;
Andersen, Andreas;
Maytham, Kaisar B.;
Andreasen, Christine R.;
Engberg, Susanne;
Lindhardt, Tommi B.;
Faber, Jens;
Holst, Jens J.;
Forman, Julie L.;
Pedersen‐Bjergaard, Ulrik;
Knop, Filip K.;
Vilsbøll, Tina

Publication type:

Article

Alleviation of functional iron deficiency by SGLT2 inhibition in patients with type 2 diabetes.

Published in:

Diabetes, Obesity & Metabolism, 2023, v. 25, n. 5, p. 1143, doi. 10.1111/dom.14963

By:

Packer, Milton

Publication type:

Article

Anagliptin twice‐daily regimen improves glycaemic variability in subjects with type 2 diabetes: A double‐blind, randomized controlled trial.

Published in:

Diabetes, Obesity & Metabolism, 2023, v. 25, n. 5, p. 1174, doi. 10.1111/dom.14959

By:

Lee, Yong‐ho;
Kim, Doo‐Man;
Yu, Jae Myung;
Choi, Kyung Mook;
Kim, Sin Gon;
Park, Kang Seo;
Son, Hyun‐Shik;
Chung, Choon Hee;
Ahn, Kyu Jeung;
Lee, Soon Hee;
Song, Ki‐Ho;
Kwon, Su Kyoung;
Park, Hyeong Kyu;
Won, Kyu Chang;
Jang, Hak Chul

Publication type:

Article

Diabetes, Obesity and Metabolism.

Published in:: Diabetes, Obesity & Metabolism, 2023, v. 25, n. 5, p. 1141, doi. 10.1111/dom.14752
Publication type:: Article